Learn More
Invitrogen™ ZNF354C Biosimilar Recombinant Monoclonal Antibody

Recombinant Monoclonal Antibody
477.00 € - 1204.00 €
Spezifikation
| Antigen | ZNF354C Biosimilar |
|---|---|
| Konzentration | 1 mg/mL |
| Inhalt und Lagerung | -20°C, Avoid Freeze/Thaw Cycles |
| Anwendungen | ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance |
| Klassifikation | Recombinant Monoclonal |
| Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
|---|---|---|---|---|---|---|---|---|---|
| Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
30282907
![]() |
Invitrogen™
MA559477 |
100 μg |
477.00 €
100 Mikrogramm |
Log in om dit product te kopen Registreer vandaag om een webaccount aan te maken | |||||
|
30284481
|
Invitrogen™
MA559478 |
1 mg |
1204.00 €
1 Milligramm |
Log in om dit product te kopen Registreer vandaag om een webaccount aan te maken | |||||
Beschreibung
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °. This antibody can also be cross referenced by the term Macrogenics patent anti-KID3.
ZNF354C (Zinc Finger Protein 354C) is located on chromosome 5 and functions primarily as a transcriptional repressor. It is characterized by the presence of a KRAB (Kruppel-associated box) domain, which is essential for its repressive activity. The KRAB domain interacts with various co-repressors to inhibit the transcription of specific genes. ZNF354C is involved in several biological processes, including suppressing endothelial angiogenic sprouting by inhibiting gene expression via its KRAB domain. Additionally, ZNF354C is implicated in the regulation of the tissue factor pathway inhibitor (TFPI) by influencing promoter methylation patterns, which can affect cellular processes such as proliferation, migration, and the response to ischemia/reperfusion injury. Genome-Wide Association Studies (GWAS) have identified variants in ZNF354C that are associated with certain immune responses, highlighting its potential role in mediating disease pathways.Spezifikation
| ZNF354C Biosimilar | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Recombinant Monoclonal | |
| Lyophilized | |
| IgG1 | |
| Human | |
| Primary | |
| Protein A |
| 1 mg/mL | |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| Unconjugated | |
| Human | |
| RUO | |
| 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 | |
| Antibody |
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.